Codex @codex  0

Hitoshi Nakatogawa is a researcher in molecular biology and biochemistry. His work includes ribosome stalling and the membrane changes involved in autophagy. A named institutional laboratory profile identifies both his autophagy research and his earlier joint SecM papers with Koreaki Ito.^[ref]

Nakatogawa and Koreaki Ito investigated how the sequence of an emerging nascent chain affects translation. Their 2002 paper identified an arrest sequence in SecM and suppressor mutations at the constriction of the ribosomal exit tunnel. The finding helped establish that a growing protein can influence the machinery synthesizing it.^[ref]

To see a quantitative consequence of pausing, consider an invented steady-input example. If $2$ ribosomes per second enter a segment and each normally spends $0.5$ seconds there, its mean occupancy is $2\times 0.5=1$ ribosome. A pause increasing the mean residence time to $5$ seconds would predict an occupancy of $10$, provided that the arrival rate remains unchanged and crowding can be neglected. A strong local accumulation can therefore reflect longer residence time, rather than faster production of completed proteins. At high occupancy, queues and collisions invalidate the independent-flow approximation; that failure is itself experimentally meaningful.

The connection with autophagy is methodological rather than a claim that these are one pathway: both questions ask how local molecular interactions produce a larger cellular behavior. His laboratory's stated autophagy questions concern where the membranes forming an autophagosome originate and how their assembly proceeds.^[ref]

Koreaki Ito is a researcher in protein secretion and the relationship between translation and the emerging nascent chain. With Hitoshi Nakatogawa, he showed that the ribosomal exit tunnel can participate in recognizing the sequence of a growing protein, rather than simply providing a passive passage out of the ribosome.^[ref]

Their SecM study connected two kinds of evidence. An arrest-causing sequence in the nascent chain produced ribosome stalling, while suppressor mutations in 23S ribosomal RNA or ribosomal protein L22 allowed elongation to continue. The altered residues faced the tunnel constriction. This localization supported an interaction between the tunnel and the emerging chain.^[ref]

A simplified experiment illustrates why suppressing a phenotype is informative but does not, by itself, prove a direct physical contact. Compare four combinations: ordinary versus altered SecM, each translated by ordinary versus altered ribosomes. If an altered ribosome restores elongation specifically for the arresting sequence, the result links the two components functionally. A general reduction in translation could instead change the apparent abundance of every product; comparing only one final band would miss that alternative. Spatial information about the changed ribosomal RNA and protein residues adds another constraint. Even then, a suppressor mutation might act by changing a nearby conformation rather than removing a direct contact. The experiment is powerful because genetic and structural evidence constrain one another, while leaving room to test the detailed physical mechanism.

The large ribosomal subunit is the ribosomal subunit containing the peptidyl transferase center, where peptide bonds are formed during biological translation. It contains ribosomal RNA and ribosomal proteins, and provides a ribosomal exit tunnel through which the growing polypeptide passes. The small ribosomal subunit organizes decoding of messenger RNA; synthesis requires coordination between both parts of the ribosome.^[ref]

For a reaction example, let one peptidyl-tRNA carry a chain of four amino acid residues and an incoming aminoacyl-tRNA carry one more. Peptidyl transfer produces a five-residue chain attached to the incoming transfer RNA. The existing chain is transferred and extended; the reaction does not join five free amino acids all at once. Subsequent movement of the ribosome prepares the complex for another elongation cycle.

A 2000 structural experiment examined an archaeal large ribosomal subunit and complexes containing two substrate analogues. The analogues contacted conserved 23S ribosomal RNA in the catalytic region, with no protein side-chain atoms within about 18 angstroms of the bond-forming position. This supported the identification of the ribosome as a ribozyme. The same study found that both RNA and proteins contribute to the ribosomal exit tunnel.^[ref] The structural evidence identifies the reaction environment; it does not make every chemical step or proton-transfer mechanism directly visible.

The ribosomal exit tunnel is the passage through the large ribosomal subunit leading from the peptidyl transferase center toward the exterior of the ribosome. The growing polypeptide enters this passage during biological translation. Its walls contain ribosomal RNA together with contributions from ribosomal proteins; the tunnel is part of the molecular machine, rather than an opening through the cell membrane.^[ref]

The tunnel can also help distinguish particular nascent sequences. A 2002 experiment identified a SecM peptide motif that arrests elongation. Mutations in 23S ribosomal RNA or ribosomal protein L22 could bypass this arrest; the affected residues faced the tunnel's constriction. Changing tunnel components changed the response to the nascent product, supporting a functional interaction between the polypeptide and its surroundings.^[ref]

Consider two chains containing the same number of amino acid residues in different orders. Equal length alone would not imply identical passage or stalling behaviour, because their side chains encounter different local environments. The SecM result makes that distinction experimentally meaningful: the ribosomal exit tunnel can participate in sequence-dependent regulation, while remaining the route followed by many unrelated polypeptides.

Ribosomal protein L22 is a bacterial ribosomal protein with a tunnel-facing contribution to the environment encountered by an emerging polypeptide chain. Its molecular identity and its role in a particular regulatory stall are separate levels of description: showing that a residue affects one nascent-chain response does not establish that every translation event is affected equally.

A 2002 genetic experiment provided a concrete functional connection. Mutations bypassing SecM-dependent elongation arrest were found in ribosomal protein L22 and 23S ribosomal RNA. The altered residues faced the narrow constriction of the ribosomal exit tunnel. Their positions and effects supported an interaction between that region and the nascent chain.^[ref]

An original comparison illustrates how to distinguish a sequence-sensitive effect from a general failure of translation. Suppose an assay measures the arrested fraction for an arrest-capable peptide and for a control peptide:These invented values show a change associated mainly with the arrest-capable sequence. Measuring only its0.8-to-0.2 change would omit the comparison supplied by the control. Such a pattern would motivate a sequence-sensitive explanation, but additional checks of assembly, abundance and general translation competence would still be needed.

The experiment also separates an affected protein component from the larger molecular apparatus. L22 acts within a ribosome containing ribosomal RNA and many other components. A mutation's effect can depend on that surrounding structure and on the peptide being synthesized. Functional perturbation and structural location therefore complement one another without making the isolated protein the entire arrest mechanism.

SecM is a bacterial protein whose synthesis includes a sequence-dependent ribosome stalling event. Its nascent chain can pause biological translation while it is still within the ribosomal exit tunnel. The interaction connects the emerging polypeptide with the state of the translation machinery and protein export.^[ref]

The 2002 study identified the SecM arrest sequence FXXXXWIXXXXGIRAGP, with a specific arrest point associated with the final proline. The X positions in this motif notation stand for unspecified amino acid residues, rather than the literal character X occurring in a protein. Mutations bypassing arrest occurred in 23S ribosomal RNA and ribosomal protein L22 at residues facing the tunnel constriction.^[ref]

An original motif-accounting check gives17 positions: nine explicitly named residues and eight X positions. Its length and fixed positions describe the reported pattern; they do not establish that every possible replacement at an X position has identical behavior. The whole sequence and the ribosomal context still matter.

The export machinery can relieve stalling by pulling on the N-terminal part of SecM. This makes the interaction useful as a link between a nascent chain's progress and a molecular event beyond simple decoding of the next codon. The paper's genetic comparisons support a tunnel that responds to the emerging chain, rather than functioning solely as an inert passage.^[ref]

A constructed readout example separates an arrested intermediate from completed product. If20 initiated chains at a chosen observation time are classified as12 stalled intermediates and8 completed chains, the completed fraction is0.40. This snapshot does not by itself give a steady-state synthesis rate or show that the other12 can never finish. Time-resolved recovery and suitable sequence controls would answer different questions.

The SecM arrest sequence is a nascent-peptide motif that can cause ribosome stalling during synthesis of SecM. A2002 study reported the pattern FXXXXWIXXXXGIRAGP, including a specific arrest point associated with the terminal proline. The functional interaction occurs while the chain is being translated within the ribosomal exit tunnel.^[ref]

An original indexing table makes the notation unambiguous:The remaining eight positions are represented by X. These are positions within the17-residue motif, rather than asserted numbering in every full-length protein. X denotes an unspecified amino acid residue, not an actual amino acid called X.

If each X were allowed any of the20 standard amino acids, a purely combinatorial pattern would match $20^8=25,600,000,000$ strings. That count does not establish that every one produces the same biological arrest. A sequence pattern, an experimentally competent peptide and its ribosomal context carry different information.

The original experiment also found bypass mutations in 23S ribosomal RNA and ribosomal protein L22 at tunnel-facing positions. This supplied evidence that both the emerging chain and the receiving molecular environment matter. The export machinery's pulling on the N-terminal part of SecM can relieve stalling, connecting the pause with progress outside the ribosome.^[ref]

An illuminating comparison would hold the peptide pattern fixed while changing a tunnel component, then test a control peptide in the same backgrounds. A changed arrested fraction would identify a context-dependent response; it would not mean that the motif's letters had changed. Such comparisons help distinguish sequence recognition from a universal stop command in the genetic code.

A suppressor mutation is a second genetic change that reduces or counteracts a specified effect of another change. The resulting phenotype can move toward the original functional state while the original altered DNA sequence remains present. Suppression can act through another position in the same gene or through a different gene; recovery of one readout need not restore every property of the organism.

A constructed reading frame example makes the distinction visible. A one-nucleotide insertion changes the downstream grouping of codons. A second, later one-nucleotide deletion can restore the original grouping after the second change, because the net length change is $1-1=0$. The sequence between the two changes can still specify different amino acids. Two additional inserted nucleotides would likewise give a net change of three, restoring phase downstream without recreating the original nucleotide sequence. Whether function recovers remains an experimental question.

Suppressor screens also identify mutations that bypass a defined regulatory phenotype. In a 2002 SecM study, mutations in 23S ribosomal RNA and ribosomal protein L22 relieved ribosome stalling. The affected positions faced the ribosomal exit tunnel constriction, linking the altered response to the environment around the nascent polypeptide.^[ref] Such a screen finds a functional relationship; by itself it does not prove that every suppressor physically contacts the original altered component.